↓ Skip to main content

Dove Medical Press

Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method

Overview of attention for article published in Drug Design, Development and Therapy, October 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
26 Mendeley
Title
Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method
Published in
Drug Design, Development and Therapy, October 2021
DOI 10.2147/dddt.s327193
Pubmed ID
Authors

Rehab Abdelmonem, Menna M Abdellatif, Inas Essam Ibrahim Al-Samadi, Mohamed A El-Nabarawi

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 12%
Unspecified 2 8%
Student > Doctoral Student 1 4%
Student > Bachelor 1 4%
Professor 1 4%
Other 3 12%
Unknown 15 58%
Readers by discipline Count As %
Unspecified 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Social Sciences 2 8%
Engineering 2 8%
Agricultural and Biological Sciences 1 4%
Other 2 8%
Unknown 15 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2023.
All research outputs
#8,588,963
of 25,508,813 outputs
Outputs from Drug Design, Development and Therapy
#645
of 2,272 outputs
Outputs of similar age
#163,709
of 437,138 outputs
Outputs of similar age from Drug Design, Development and Therapy
#8
of 40 outputs
Altmetric has tracked 25,508,813 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,272 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,138 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.